Business ❯Pharmaceuticals

Competition

Pneumococcal Vaccine Weight Loss Drugs Injectable Treatments AstraZeneca Eli Lilly

Zealand Pharma's Petrelintide Shows Promising Results in Early Weight Loss Trial

The drug demonstrated significant weight reduction and favorable tolerability, positioning it as a potential alternative to current market leaders.

FDA Approves Merck's New Adult Pneumococcal Vaccine Capvaxive

Eli Lilly Faces Zepbound Shortage, Impacting Weight Loss and Diabetes Patients